You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Mary Jane Jasin v. Vivus, Inc. (N.D. Cal. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Mary Jane Jasin v. Vivus, Inc. (N.D. Cal. 2014)

Docket	⤷ Sign Up	Date Filed	2014-07-18
Court	District Court, N.D. California	Date Terminated
Cause	15:78m(a) Securities Exchange Act	Assigned To	Beth Labson Freeman
Jury Demand	Plaintiff	Referred To	Magistrate Judge Howard R. Llo
Patents	6,071,537
Link to Docket	External link to docket

Small Molecule Drugs cited in Mary Jane Jasin v. Vivus, Inc.

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Details for Mary Jane Jasin v. Vivus, Inc. (N.D. Cal. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2015-06-18	31		9 obesity,” and the “Shank Patent,” U.S. Patent No. 6,071,537, which was held by Johnson & … 7 1999 patent filed by Dr. Susan McElroy, the “McElroy Patent,” U.S. Patent No. 6,323,236, … 6 other patents which they contend posed risks to the Najarian Patent: an earlier filed February…an August 25, 2014 transfer of the patent to Vivus, which patented topiramate alone … all related patent applications, 16 or the Patents, were transferred	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.